[1] |
MA Yan, TIAN Gaopeng, SHI Xingwen, SUN Ting, XIE Jingjing, ZHEN Donghu.
Correlation between 25(OH)D and metabolically related fatty liver in T2DM population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1018-1026.
|
[2] |
HOU Ruiying, GUO Lige, JIAO Weijie, DU Lei, WU Guiyue, ZHAO Xu.
Effects of Xiaokeshu recipe on levels of serum inflammatory factors in type2 diabetic rats and its mechanism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 377-382.
|
[3] |
ZHAI Weiwei, YU Qiaoling, LIU Ping, QIU Bo, WU Huizhen.
Research progress of finerenone in the treatment of type 2 diabetes mellitus complicated with chronic kidney disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 1067-1074.
|
[4] |
LU Senlin, LIU Xinyuan, WANG Jili, HUANG Xiaofei.
Research progress of virus-mediated gene therapy in type 2 diabetes mellitu
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 800-807.
|
[5] |
DAI Hongyu, YANG Kun, HU Ruchun, ZHOU Hongmei, MA Peimin, HAO Qian.
Duration time and effectiveness of 0.25%ropivacaine for sciatic nerve block in patients with diabetes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1278-1284.
|
[6] |
XU Yongxia, XIE Mingzhu, GONG Muxue, HUANG Jiaying, ZHAO Li, ZHU Defa.
Effects of 25(OH)D on islet β-cells function in the elderly with type 2 diabetes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1021-1026.
|
[7] |
ZHAO Hailing, ZHANG Haojun, ZHAO Tingting, YAN Meihua, DONG Xi, MA Liang, LI Ping.
Association between the polymorphism of PNPLA2 gene and the risk of ischemic stroke in type 2 diabetic patients in Chinese Han Population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 664-669.
|
[8] |
YANG Leixi, FENG Kai, FAN Xueting, WEI Yanchun, LIU Tingting, TANG Yiqun.
Novel compound HYY-002 inhibits paroxysmal atrial fibrillation in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(12): 1347-1352.
|
[9] |
XU Shengsong, TAO Hui, SHI Kaihu, DING Jifei.
Expression and clinical significance of EZH2 and α-SMA in myocardium of patients with rheumatic heart disease with atrial fibrillation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(12): 1371-1375.
|
[10] |
YE Shengkai, WEN Jie, LIU Weiping, REN Xia, CHEN Haiying, DU Ying, LI Xue, ZHANG Ru, YU Li, ZHANG Biying.
Effects of dapagliflozin on intima-medial thickness of carotid artery in type 2 diabetic mellitus patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(7): 814-819.
|
[11] |
ZHONG Ling, SHAO Hua, CHEN Yan, HU Linlin, YU Feng.
Advance in linezolid-induced thrombocytopenia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(10): 1196-1200.
|
[12] |
WU Haibing, ZHANG Gang, HAN Bin, GUO Xiaojun, JI Zhaoning.
Clinical features and risk factors for infecfions in multiple myeloma during chemotherapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(1): 93-98.
|
[13] |
ZHANG Chunyan, FAN Xiaodong, QIN Yuan, KONG Wenqiang, ZHOU Chunyang, DU Biao.
Markov model to assess long-term effects of teneligliptin in treatment of type 2 diabetes mellitus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(1): 65-72.
|
[14] |
SONG Meiqing.
Effect of metformin on bone mineral density, insulin resistance and cytokines in type 2 diabetes mellitus patients with primary hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 694-698.
|
[15] |
LIU Chang, JIANG Daoli, LIU Xiaofang, XU Jia, WANG Lijue, WANG Qian, XU Ling, FANG Yi.
Establishment of rat model of type 2 diabetes induced by streptozotocin combined with cerebral ischemic reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 518-525.
|